Navigation Links
Protectus Medical Devices Appoints as Medical Director a Physician Surgeon With 20-Year Involvement in Senior Level Monitoring of Pharmaceutical and Medical Devices
Date:8/19/2010

nge, and soon to be announced Phlebotomy device.

About Protectus Medical Devices, Inc. (formerly, E-18 Corp.)Protectus Medical Devices, Inc. (PTMD, formerly, E-18 Corp.), through its wholly owned subsidiary, SquareOne Medical, Inc., develops and markets innovative safety medical percutaneous devices that, collectively, have the potential to dramatically reduce needlestick injuries for medical professionals worldwide. In the nearly $5 billion global hypodermic syringe market, the Protectus Safety Syringe, the Company's lead product, is the only fully automatic, self-sheathing hypodermic safety syringe that currently meets the functional definition of "Self-Sheathing" mandated by the U.S. Federal Government. None of the manufacturers of other devices on the market can make this claim. Protectus Medical Devices has successfully patented its automatic, self-sheathing hypodermic safety syringe product, and, based on the results of full comparison clinical trials, the Protectus Safety Syringe (formerly the SquareOne Safety Syringe) has received the required 510(k) permission from the U.S. FDA to manufacture and market the device in the U.S. More information about the Company may be found at www.protectusmedical.com.

Forward-Looking StatementsThis release contains "forward-looking statements" for purposes of the Securities and Exchange Commission's "safe harbor" provisions under the Private Securities Litigation Reform Act of 1995 and Rule 3b-6 under the Securities Exchange Act of 1934. These forward-looking statements are subject to various risks and uncertainties that could cause the business and financial results of Protectus Medical Devices, Inc. to differ materially from those currently anticipated, including the risk factors identified in Protectus Medical Devices, Inc.'s filings with the Securities and Exchange Commission.Company Contact:Protectus Medical Devices, Inc. John Salstrom, President and CE
'/>"/>

SOURCE Protectus Medical Devices, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. US Patent Allowed for Spring Action That Separates Protectus Innovative Safety Syringe From All Others
2. Advanced Web-Based Medical Technologies Foster Better Informed Consumers, Greater Interest in Personal Health Care
3. Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs
4. Concord Medical Announces Second Quarter 2010 Financial Results
5. Luminex Donates Companys First MAGPIX Multiplexing System to Papua New Guinea Institute of Medical Research
6. VirtuOx and Watermark Medical Announce Strategic Alliance to Expand Sleep Apnea Home Sleep Testing Solutions
7. Varian Medical Systems to Showcase Advanced Motion Management Technology for the Treatment of Lung Cancer at CHINA-HOSPEQ 2010
8. Dehaier Medical Systems Q2 Revenue Up 46% to $4.83 Million; Net Income Up 59% to 1.14 Million; EPS 0.27
9. UCI Medical Affiliates, Inc. Reports Third Quarter Results for Fiscal Year 2010
10. Medco Announces Agreement to Acquire United BioSource Corporation: A Global Medical Research and Scientific Services Leader to Advance Drug Safety and Knowledge
11. China Medical Technologies Reports First Fiscal Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... PHOENIX , Aug. 20, 2014 ... cutting-edge next-generation sequencing and proteomic diagnostics and biomarker ... a collaboration with TESARO, Inc.  Paradigm will use ... samples from clinical trials to better predict which ... TSR-011.  This may lead to more successful clinical trial ...
(Date:8/20/2014)... Aug. 20, 2014 Reportlinker.com announces that ... its catalogue: The Market for Medical ... The European, Middle Eastern and African markets ... As part of its coverage, this study: The ... the EMEA medical device markets and estimates markets ...
(Date:8/20/2014)... Texas , Aug. 20, 2014  Quantum ... five diverse sets of patent families from Bayer Technology ... innovation driver for Bayer AG of Leverkusen, ... patents acquired provide broad intellectual property protection for ... economical high-volume quantum dot (QD) manufacturing. In addition, ...
Breaking Medicine Technology:Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc. 2The Market for Medical Devices in EMEA 2The Market for Medical Devices in EMEA 3The Market for Medical Devices in EMEA 4The Market for Medical Devices in EMEA 5Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 2Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 3Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 4
... DIEGO, Feb. 3, 2011 Ceregene, Inc., a biopharmaceutical ... and dosing in its CERE-120 (AAV2-neurturin) Phase 2b multi-center, ... was initiated in October 2010 and all 11 centers ...  These sites are among the best movement disorders centers ...
... 3, 2011 Corium International, Inc., a privately-held ... appointment of Dr. Bhaskar Chaudhuri and David L. ... most recently served as President of Valeant Pharmaceuticals ... Officer of Dow Pharmaceutical Services, Inc.  Mr. Greenwood ...
Cached Medicine Technology:Ceregene Advances Phase 2b CERE-120 (AAV2-neurturin) Trial in Parkinson's Disease 2Ceregene Advances Phase 2b CERE-120 (AAV2-neurturin) Trial in Parkinson's Disease 3Ceregene Advances Phase 2b CERE-120 (AAV2-neurturin) Trial in Parkinson's Disease 4Ceregene Advances Phase 2b CERE-120 (AAV2-neurturin) Trial in Parkinson's Disease 5Corium International Adds Dr. Bhaskar Chaudhuri and David Greenwood to Board of Directors 2Corium International Adds Dr. Bhaskar Chaudhuri and David Greenwood to Board of Directors 3
(Date:8/20/2014)... 20, 2014 Understanding the impact ... physician stakeholders networks impacting the launch of new ... Canada, and Emerging Markets. , This Flash Report ... on stakeholder management needs for the melanoma market. ... targeted therapy investigational agents that are further improving ...
(Date:8/20/2014)... 2014 The award-winning plastic surgery group, ... its presence throughout Houston to a third office, located ... Laser Center building. ACPS plastic surgeon Dr. Rolando Morales ... ACPS, which has risen to become one of the ... the state since its establishment in 1996 by plastic ...
(Date:8/20/2014)... technique that underpins much of modern science, Chemical ... a special edition on X-ray crystallography its past, ... is the weekly news magazine of the American Chemical ... technique got its start when German physicist Max von ... a crystal in 1912. In the century following von ...
(Date:8/20/2014)... 2014 According to an order signed ... in the multicounty litigation (MCL) case pending in the ... HIP IMPLANTS LITIGATION; no. BER-L-3971-11), nearly 350 lawsuits against ... without prejudice. The cases enumerated in the order of ... The Rottenstein Law Group LLP, a national personal injury ...
(Date:8/20/2014)... 2014 It’s no secret that millions ... the National Institute on Drug Abuse, nearly 24 million ... even more alarming is the fact that the total ... , Those locked in a struggle with substance abuse ... But now, the newly-redesigned AbuseTreatmentCenters.net has released updated lists ...
Breaking Medicine News(10 mins):Health News:Download HeartBeat Experts White Paper: A Stakeholder Engagement Strategy is Critical for the Evolving Melanoma Treatment Setting 2Health News:Aesthetic Center for Plastic Surgery Expands Its Reach in Texas 2Health News:350 NJ DePuy ASR Lawsuits Dismissed Pending Settlement Talks, Notes Rottenstein Law Group LLP 2Health News:Re-Launched AbuseTreatmentCenters.net Offering New List of Substance Abuse Resources 2
... A research finds that the sea urchin's genome is remarkably ... to preventing and curing several human diseases. //University of Central ... study and published the results in the November issue of ... and spiny and have no eyes. The sea urchin has ...
... of cartilage in joints, is likely to be more ... led by David Felson, a professor at the Boston ... of the knee for 30 months. Twelve percent of ... of BBC News. ,The researchers found that ...
... Hopkins Children’s Center and elsewhere suggests that only one ... medicine to control dangerous flare-ups of the disease. ... researchers say, because preventive therapy failure leads to over-reliance ... and to more complications and increased risk of death. ...
... for depression. Even if you are under medical care and ... December issue of Mayo Clinic Women's HealthSource offers five self-care ... risk of recurrence. ,1. Keep active. As ... days has been shown to improve mood. Long-term regular exercise ...
... juvenile diabetics, it is not surprising that parents are a ... What used to be a malady of the middle aged ... that parents and doctors recognize the symptoms early, lest matters ... the International Diabetes Federation (IDF) corroborates this unhealthy trend of ...
... reason why teenage years are perceived as 'tumultuous'. When ... Box has opened. //Such teens are prone to misusing ... a recent insight indicates. ,The Canadian Centre on ... among 15- to 19-year-olds, drawing on the strength of ...
Cached Medicine News:Health News:Sea Urchin Genome Similar To Man And May Cure Diseases 2Health News:City Kids With Asthma Lose Out on Preventive Treatment 2Health News:Five Self-Care Strategies For Depression 2
0.12 mm, 1 x 2 teeth. Serrated handle with polished finish....
Stainless steel model of the popular Nordan titanium Colibri forceps. Tying platform with 0.12 mm teeth for grasping delicate structures. Flattened round handle with polished finish....
0.4 mm, 1 x 2 teeth 7 mm tying platform. Serrated handle with polished finish....
Solid lower plate with outside width 15 mm. Open serrated upper plate with inside dimensions 9 x 12 mm. Serrated handle with locking thumb screw and polished finish....
Medicine Products: